BUSINESS

U.S. firms announce share sales and product updates

PUBLISHED Apr 6, 2026, 7:59 AM ET

Read, Watch or Listen

Media Bias Meter

Sources: 12

Center 100%

Sources: 12

San Jose, Calif. — On April 6, 2026, selling stockholders affiliated with Blackstone announced plans to offer 11,000,000 Class A shares of Legence Corp. in a secondary underwritten public offering, with Goldman Sachs, Jefferies and BofA named as joint lead managers and a 30-day option for additional shares. Arlington, Va., Frederick, Md., and Miami report related activity this week: Fluence reaffirmed U.S.-manufactured products qualify for domestic-content tax credits under the One Big Beautiful Bill Act; TOMI reported about a dozen SteraMist partnerships amid tighter pharmacy regulations; Real Brokerage set a May 7, 2026, Q1 results call.

By Emily Rhodes | JQJO News

Timeline of Events

April 6, 2026 — Legence announces selling stockholders affiliated with Blackstone intend to offer 11,000,000 Class A shares.
April 6, 2026 — Underwriters named: Goldman Sachs, Jefferies and BofA; 30-day option for 1,650,000 additional shares disclosed.
April 6, 2026 — Fluence Energy confirms U.S.-manufactured products remain eligible for domestic-content tax credits under the One Big Beautiful Bill Act.
April 6, 2026 — TOMI announces approximately a dozen SteraMist partnerships driven by tighter compounding pharmacy regulations and USP standards.
May 7, 2026 — The Real Brokerage will release first-quarter 2026 financial results and host a conference call at 8:00 a.m. ET.

News Intelligence

The Blackstone-affiliated stock sale could affect Legence Corp's share price. If you own their stock, keep an eye on it. Fluence's tax credit eligibility means their U.S.-made products might stay cost-friendly. TOMI's SteraMist partnerships could impact pharmacy safety standards.

Media Bias

Articles Published:: 12
Right Leaning:: 0
Left Leaning:: 0
Neutral:: 12

Who Benefited

Underwriters, the selling stockholders affiliated with Blackstone, manufacturers meeting domestic-content requirements, and vendors of compliance and decontamination technologies gained liquidity, contract opportunities, and potential demand increases from announced offerings, tax-credit qualification, and regulatory-driven procurement.

Who Impacted

Public shareholders and short-term investors in the affected firms may face share-price pressure or volatility, while Legence will incur costs related to the offering despite receiving no proceeds, and compounding pharmacies face higher compliance burdens from tightened oversight.

Media Bias